John Qpublic @Jamesbridgebuilder
13 November, 10:59
Small Pox has always been the next step.

FDA approved a pill for small pox in 2018.
Yes a pill for a disease that is eradicated in the U.S.
Their excuse is just in case of bio-terrorism.
A company called SIGA got the call and has a contract with BARDA (The Biomedical Advanced Research and Development Authority) to supply the drug.

Here is the catch though and it's freaking HUGE.
"The efficacy of TPOXX may be reduced in immunocompromised
patients." A.K.A. everyone with a covid vax.
It gets much worse.
A dedicated drug-drug interaction study determined that drug interactions exist for co-administration of repaglinide and midazolam.
Wouldn't you know that both of those drugs are used in a form of a Covid vaccine.

So not only will it not work well but you could have deaths from drug interactions out the wazzu.
BTW SIGA is Agis backward. Agis is a huge elder health network.

This is a set up, it always was. They are trying to sacrifice those you love.
BE VERY AFRAID.

Notice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396
Crumb Catcher @CrumbCatcher
15 November, 03:21
In response John Qpublic to his Publication
I read in Agenda 21 they planned on throwing Non compliant people into the infested South (Where I am). They targeted certain areas to release this. Dear lord.

Notice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396
John Qpublic @Jamesbridgebuilder
Yes they do plan to do that. What is in our favor now is that people are starting to see that A21 isn't a conspiracy theory, it is the truth.
We may be stupid but we will not allow this to happen again. Our people will stand up and do so in overwhelming numbers.
07:01 AM - Nov 16, 2021
In response Crumb Catcher to her Publication
Only people mentioned by Jamesbridgebuilder in this post can reply

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from John Qpublic, click on at the bottom under it